CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

Alzheimer’s Drug

metabolic solutions

Kalamazoo Firm Presents Clinical Trial Results Of Alzheimer’s Drug

Metabolic Solutions Development Co. LLC announced that Jerry Colca, co-founder and chief scientific officer of MSDC, presented results of a Phase 2a study at the 14th International Conference on Alzheimer’s Drug Discovery.

WWJ Newsradio 950–09/09/2013

ALZHEIMERS

Metabolic Solutions To Present On Alzheimer’s Drug

Metabolic Solutions Development Co. LLC will provide an update on the clinical evaluation of MSDC-0160, a compound being investigated in an ongoing Phase 2a trial in subjects with mild to moderate dementia due to Alzheimer’s disease, at the Alzheimer’s Drug Discovery Foundation 13th International Conference on Alzheimer’s Drug Discovery in Jersey City, N.J. Sept. 10.

WWJ Newsradio 950–09/09/2012

metabolic solutions

Kalamazoo Pharma Gets Foundation Grant For Trial Of Alzheimer’s Drug

Kalamazoo-based Metabolic Solutions Development Co. said Wednesday that it has received a $773,000 grant from the Alzheimer’s Drug Discovery Foundation to conduct a pilot Phase 2a trial of MSDC-0160, MSDC’s pioneer compound for the treatment of metabolic diseases associated with altered mitochondrial function.

WWJ Newsradio 950–07/06/2011

adeona

Adeona Loss Drops On Revenue Jump

The Ann Arbor-based pharma startup Adeona Pharmaceuticals Inc. (Amex: AEN) reported a lower loss on sharply higher revenue for 2010 over 2009.

03/31/2011

Follow

Get every new post delivered to your Inbox.

Join 1,870 other followers